{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:20:57Z","timestamp":1784996457854,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>No publications have reported on osteomalacia in patients receiving intermittent cyclical therapy with etidronate (a bisphosphonate) and undergoing long-term hemodialysis (HD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report on a 46-year-old Japanese man admitted to our hospital for further examination of left forearm pain. Maintenance HD was started at age 24\u2009years, and the man had been on HD since then. At age 38\u2009years, surgical parathyroidectomy was performed for secondary hyperparathyroidism; iliac crest bone biopsy performed at the same time showed osteitis fibrosa. The active vitamin D<jats:sub>3<\/jats:sub> preparation calcitriol was started, and intermittent cyclical etidronate therapy was introduced 2\u2009years later for osteoporosis. At age 45\u2009years, the patient stopped taking calcitriol because of hypercalcemia but continued with etidronate. At age 46\u2009years, a pseudofracture with a Looser zone occurred in the left ulna, and left femur bone biopsy revealed osteomalacia. Etidronate was discontinued, and calcitriol was restarted; open reduction and internal fixation with an angular stability plate were performed. Union of the bone was achieved 10\u2009months after the operation. At age 49\u2009years, a lumber bone biopsy confirmed improved bone morphometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We believe that intermittent cyclical etidronate therapy without administration of active vitamin D<jats:sub>3<\/jats:sub> during long-term HD might have induced osteomalacia, resulting in the ulna insufficiency fracture. Therefore, we propose that administration of active vitamin D<jats:sub>3<\/jats:sub> is essential to prevent osteomalacia in patients on long-term HD who are receiving bisphosphonates and have potential vitamin D<jats:sub>3<\/jats:sub> deficiency.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02509-5","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T08:28:04Z","timestamp":1630657684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-5604","authenticated-orcid":false,"given":"Masaki","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izuru","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seizo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Isawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"issue":"4","key":"2509_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, et al. Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by Dialysis. Am J Kidney Dis. 2016;67(4):559\u201366. https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.023.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"2509_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Improving Global Outcomes (KDIGO) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney Disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945\u201353. https:\/\/doi.org\/10.1038\/sj.ki.5000414.","journal-title":"Kidney Int"},{"issue":"2","key":"2509_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, et al. The Spectrum of bone Disease in end-stage renal failure--an evolving disorder. Kidney Int. 1993;43(2):436\u201342. https:\/\/doi.org\/10.1038\/ki.1993.64.","journal-title":"Kidney Int"},{"issue":"2","key":"2509_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jbmr.5650030203","volume":"3","author":"RR Recker","year":"1988","unstructured":"Recker RR, Kimmel DB, Parfitt MA, et al. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res. 1988;3(2):133\u201344. https:\/\/doi.org\/10.1002\/jbmr.5650030203.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2509_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1523-1755.2005.00464.x","volume":"68","author":"Y Ubara","year":"2005","unstructured":"Ubara Y, Tagami T, Nakanishi S, Sawa N, Hoshino J, Suwabe T, et al. Significance of Minimodeling in Dialysis patients with Adynamic bone Disease. Kidney Int. 2005;68(2):833\u20139. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00464.x.","journal-title":"Kidney Int"},{"issue":"4","key":"2509_CR6","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00198-014-2987-8","volume":"26","author":"K Sumida","year":"2015","unstructured":"Sumida K, Ubara Y, Hoshino J, et al. Bone histomorphometry in a long-term hemodialysis patient with hypoparathyroidism and sarcoidosis. Osteoporos Int. 2015;26(4):1435\u201341.","journal-title":"Osteoporos Int"},{"issue":"6","key":"2509_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","volume":"92","author":"A Pimentel","year":"2017","unstructured":"Pimentel A, Ure\u00f1a-Torres P, Zillikens MC, Bover J, Cohen-Solal M. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European calcified tissue society and the European renal Association of Nephrology Dialysis and Transplantation. Kidney Int. 2017;92(6):1343\u201355. https:\/\/doi.org\/10.1016\/j.kint.2017.07.021.","journal-title":"Kidney Int"},{"issue":"23","key":"2509_CR8","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.2169\/internalmedicine.51.8109","volume":"51","author":"R Hiramatsu","year":"2012","unstructured":"Hiramatsu R, Ubara Y, Suwabe T, Sumida K, Hayami N, Yamanouchi M, et al. Osteomalacia and insufficiency fracture in a hemodialysis patient with autosomal dominant polycystic kidney disease. Intern Med. 2012;51(23):3277\u201380. https:\/\/doi.org\/10.2169\/internalmedicine.51.8109.","journal-title":"Intern Med"},{"key":"2509_CR9","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kid- ney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1\u2013130."},{"issue":"6","key":"2509_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","volume":"70","author":"T Isakova","year":"2017","unstructured":"Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Guti\u00e9rrez OM, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737\u201351. https:\/\/doi.org\/10.1053\/j.ajkd.2017.07.019.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"2509_CR11","first-page":"S87","volume":"38","author":"HH Malluche","year":"1992","unstructured":"Malluche HH. The possible use of bisphosphonates in the treatment of renal osteodystrophy. Clin Nephrol. 1992;38(Suppl 1):S87\u201391.","journal-title":"Clin Nephrol"},{"issue":"5","key":"2509_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/00041552-200109000-00006","volume":"10","author":"SL Fan","year":"2001","unstructured":"Fan SL, Cunningham J. Bisphosphonates in renal osteodystrophy. Curr Opin Nephrol Hypertens. 2001;10(5):581\u20138. https:\/\/doi.org\/10.1097\/00041552-200109000-00006.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"2509_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000186092","volume":"56","author":"NA Hamdy","year":"1990","unstructured":"Hamdy NA, McCloskey EV, Brown CB, et al. Effects of clodronate in severe hyperparathyroid bone disease in chronic renal failure. Nephron. 1990;56(1):6\u201312. https:\/\/doi.org\/10.1159\/000186092.","journal-title":"Nephron."},{"issue":"Suppl 3","key":"2509_CR14","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1177\/089686080102103S45","volume":"21","author":"C Rodd","year":"2001","unstructured":"Rodd C. Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues. Perit Dial Int. 2001;21(Suppl 3):S256\u201360.","journal-title":"Perit Dial Int"},{"issue":"3","key":"2509_CR15","first-page":"209","volume":"44","author":"T Ring","year":"1995","unstructured":"Ring T, Sodemann B, Nielsen C, Melsen F, Kornerup HJ. Mineralization defect but no effect on hypercalcemia during clodronate treatment in secondary hyperparathyroidism. Clin Nephrol. 1995;44(3):209\u201310.","journal-title":"Clin Nephrol"},{"issue":"6530","key":"2509_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/bmj.292.6530.1227","volume":"292","author":"CJ Gibbs","year":"1986","unstructured":"Gibbs CJ, Aaron JE, Peacock M. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. Br Med J (Clin Res Ed). 1986;292(6530):1227\u20139. https:\/\/doi.org\/10.1136\/bmj.292.6530.1227.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"2509_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s002560050608","volume":"29","author":"JR MacGowan","year":"2000","unstructured":"MacGowan JR, Pringle J, Morris VH, et al. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. Skelet Radiol. 2000;29(5):279\u201382. https:\/\/doi.org\/10.1007\/s002560050608.","journal-title":"Skelet Radiol"},{"issue":"2","key":"2509_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990;323(2):73\u20139. https:\/\/doi.org\/10.1056\/NEJM199007123230201.","journal-title":"N Engl J Med"},{"issue":"8","key":"2509_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72(8):1004\u201313. https:\/\/doi.org\/10.1038\/sj.ki.5002451.","journal-title":"Kidney Int"},{"issue":"11","key":"2509_CR20","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1093\/ndt\/gfn339","volume":"23","author":"G Jean","year":"2008","unstructured":"Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008;23(11):3670\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfn339.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2509_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00774-013-0480-7","volume":"32","author":"F Mac-Way","year":"2014","unstructured":"Mac-Way F, Azzouz L, Noel C, Lafage-Proust MH. Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction. J Bone Miner Metab. 2014;32(2):215\u20139. https:\/\/doi.org\/10.1007\/s00774-013-0480-7.","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"2509_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/ncpneph0443","volume":"3","author":"JD Hernandez","year":"2007","unstructured":"Hernandez JD, Wesseling K, Boechat MI, Gales B, Salusky IB. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol. Nat Clin Pract Nephrol. 2007;3(4):227\u201332. https:\/\/doi.org\/10.1038\/ncpneph0443.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5","key":"2509_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/sdi.12772","volume":"32","author":"ME Rodr\u00edguez-Ortiz","year":"2019","unstructured":"Rodr\u00edguez-Ortiz ME, Pend\u00f3n-Ruiz de Mier MV, Rodr\u00edguez M. Parathyroidectomy in dialysis patients: indications, methods, and consequences. Semin Dial. 2019;32(5):444\u201351. https:\/\/doi.org\/10.1111\/sdi.12772.","journal-title":"Semin Dial"},{"issue":"2","key":"2509_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00268-011-1392-0","volume":"36","author":"R Schneider","year":"2012","unstructured":"Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg. 2012;36(2):318\u201326. https:\/\/doi.org\/10.1007\/s00268-011-1392-0.","journal-title":"World J Surg"},{"issue":"5","key":"2509_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00268-005-0379-0","volume":"30","author":"K Lorenz","year":"2006","unstructured":"Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H. Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg. 2006;30(5):743\u201351. https:\/\/doi.org\/10.1007\/s00268-005-0379-0.","journal-title":"World J Surg"},{"issue":"954","key":"2509_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/pgmj.2004.026450","volume":"81","author":"RN Saunders","year":"2005","unstructured":"Saunders RN, Karoo R, Metcalfe MS, Nicholson ML. Four gland parathyroidectomy without Reimplantation in patients with chronic renal failure. Postgrad Med J. 2005;81(954):255\u20138. https:\/\/doi.org\/10.1136\/pgmj.2004.026450.","journal-title":"Postgrad Med J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02509-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02509-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02509-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T08:31:26Z","timestamp":1630657886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02509-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2509"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02509-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests and no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}